![Michael Wootton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Wootton
Directeur Général chez NF2 Therapeutics, Inc.
Profil
Michael Wootton is the President and Director of NFlection Therapeutics, Inc. which he founded in 2014.
Mr. Wootton is also the founder of NF2 Therapeutics, Inc.
Postes actifs de Michael Wootton
Sociétés | Poste | Début |
---|---|---|
NF2 Therapeutics, Inc.
![]() NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Michael Wootton
Sociétés | Poste | Fin |
---|---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 2 |
---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Health Technology |
NF2 Therapeutics, Inc.
![]() NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Commercial Services |